Corpus ID: 212575148

Bioequivalence study of two oral formulations of clarithomycin following a single dose administration to healthy male subjects under fasting conditions

@inproceedings{Alsaraf2016BioequivalenceSO,
  title={Bioequivalence study of two oral formulations of clarithomycin following a single dose administration to healthy male subjects under fasting conditions},
  author={Khulood M. Alsaraf},
  year={2016}
}
Background: Clarithromycin is a semi-synthetic macrolide antibiotic used in a wide range of bacterial infections as a single or combination therapy. Several generic formulations of clarithromycin are marketed in Iraq, but their bioavailability and hence therapeutic equivalence is not available. Therefore, demonstration of bioequivalence is warranted to determine the bioequivalence between medicinal products in Iraqi individuals. Objectives: The aim of this study was to assess bioequivalence… Expand

Figures and Tables from this paper

References

SHOWING 1-10 OF 22 REFERENCES
Clarithromycin bioequivalence study of two oral formulations in healthy human volunteers.
  • 10
Human Bioequivalence Study of Clarithromycin from Two Tablet Formulations after Single Oral Administration
  • 2
Absolute bioavailability of clarithromycin after oral administration in humans.
  • 94
  • PDF
Clinical Pharmacokinetics of Clarithromycin
  • 166
A Survey of the Quality of Generic Clarithromycin Products from 18 Countries
  • 26
The development of macrolides: clarithromycin in perspective.
  • H. Neu
  • Biology, Medicine
  • The Journal of antimicrobial chemotherapy
  • 1991
  • 101
Acceptability and characteristics of 124 human bioequivalence studies with active substances classified according to the Biopharmaceutic Classification System.
  • 56
Generic antibiotics in Japan
  • S. Fujimura, A. Watanabe
  • Medicine
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
  • 2012
  • 16
...
1
2
3
...